NachrichtenKI-unterstützt

BGS to Launch First U.S. Facility, Bringing Advanced E-Beam Sterilization to American Markets

BGS opens first U.S. E-Beam sterilization facility, offering advanced technology to meet growing demand.

Mrudula Kulkarni
Von Mrudula Kulkarni
Redaktionsleiter – Pharma Now
12. Sept. 2024Updated Jun 26, 2025 · 2 Min. Lesezeit
BGS to Launch First U.S. Facility, Bringing Advanced E-Beam Sterilization to American Markets
https://bgs.eu/en/about-bgs/
KI-unterstützte Berichterstattung
Reviewed by Mrudula Kulkarni, Redaktionsleiter – Pharma Now

BGS Beta-Gamma-Service, a leading provider of radiation sterilization for medical devices and pharmaceuticals, is set to open its first U.S. facility in mid-2025. The new 100,000-square-foot plant, located in Imperial, PA, near Pittsburgh International Airport, will offer fully automated E-Beam sterilization and will operate as BGS US. Leonard Zuba, formerly of Raumedic, will serve as general manager, with Bert Whitt, an expert in radiation sterilization, overseeing operations.

The expansion comes as U.S. manufacturers of medical and biotechnology products face growing challenges with sterilization capacity due to the limitations of traditional ethylene oxide (EtO) methods and the scarcity of Cobalt-60. BGS's advanced E-Beam technology offers a promising alternative. With three successful facilities in Germany, BGS’s U.S. expansion is aimed at addressing domestic supply chain bottlenecks and meeting the increasing demand for sterilization services.

“Pittsburgh’s proximity to key markets and the interest from potential U.S. clients made it the ideal choice for our first U.S. location,” said Zuba. The company expects its U.S. operations to play a vital role in reducing sterilization challenges for American manufacturers.

 

Mrudula Kulkarni
Written by
Mrudula Kulkarni
Redaktionsleiter – Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.



Discussion

Diskussion wird geladen…

Mehr aus Pharma News

Alle Beiträge →